AC IMMUNE SA SF-02 (IMR) — Defensive Interval Ratio

Latest as of March 2026: 220 days

AC IMMUNE SA SF-02 (IMR) has a Defensive Interval Ratio of 220 days as of March 2026. Defensive assets of €55.63 Million (cash €-, short-term investments €55.63 Million, receivables €-) cover 220 days of daily cash needs of €252.73K/day. Check AC IMMUNE SA SF-02 tangible book value ratio to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

220 days
Days of operational coverage

Defensive Assets

€55.63 Million
Cash + ST Investments + Receivables

Daily Cash Need

€252.73K
Current Liabilities ÷ 365

Current Liabilities

€92.25 Million
EUR

AC IMMUNE SA SF-02 Defensive Interval Ratio (2021–2025)

This chart shows how AC IMMUNE SA SF-02's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 220 days, meaning defensive assets of €55.63 Million can fund 220 days of operations without new revenue. Also explore IMR shareholders equity momentum to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for AC IMMUNE SA SF-02 (2021–2025)

The table below presents the year-by-year Defensive Interval Ratio for AC IMMUNE SA SF-02 from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see IMR stock market capitalisation.

Year DIR (days) Defensive Assets (EUR) Daily Cash Need Cash ST Investments Change (days)
2025 249 days €64.62 Million €259.43K/day €- €64.62 Million ▼ -219 days
2024 468 days €129.21 Million €276.27K/day €- €129.21 Million ▼ -590 days
2023 1058 days €39.35 Million €37.19K/day €- €24.55 Million ▼ -1835 days
2022 2893 days €91.00 Million €31.45K/day €- €91.00 Million ▲ +779 days
2021 2114 days €116.00 Million €54.87K/day €- €116.00 Million
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)